RUANYUN EDAI TECHNOLOGY INC (RYET) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:RYET • KYG7710T1058

1.09 USD
+0.03 (+2.83%)
At close: Feb 2, 2026
1.09 USD
0 (0%)
Pre-Market: 2/3/2026, 8:37:42 AM
Fundamental Rating

0

Overall RYET gets a fundamental rating of 0 out of 10. We evaluated RYET against 76 industry peers in the Diversified Consumer Services industry. RYET has a bad profitability rating. Also its financial health evaluation is rather negative. RYET does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year RYET has reported negative net income.
  • RYET had a negative operating cash flow in the past year.
RYET Yearly Net Income VS EBIT VS OCF VS FCFRYET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M -2M

1.2 Ratios

  • RYET has a Return On Assets of -36.57%. This is in the lower half of the industry: RYET underperforms 73.68% of its industry peers.
Industry RankSector Rank
ROA -36.57%
ROE N/A
ROIC N/A
ROA(3y)-19.9%
ROA(5y)N/A
ROE(3y)-301.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RYET Yearly ROA, ROE, ROICRYET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

  • RYET's Gross Margin of 35.20% is in line compared to the rest of the industry. RYET outperforms 42.11% of its industry peers.
  • The Profit Margin and Operating Margin are not available for RYET so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RYET Yearly Profit, Operating, Gross MarginsRYET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, RYET has about the same amount of shares outstanding.
  • RYET has a worse debt/assets ratio than last year.
RYET Yearly Shares OutstandingRYET Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
RYET Yearly Total Debt VS Total AssetsRYET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of 0.13, we must say that RYET is in the distress zone and has some risk of bankruptcy.
  • RYET has a worse Altman-Z score (0.13) than 61.84% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACCN/A
RYET Yearly LT Debt VS Equity VS FCFRYET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M

2.3 Liquidity

  • RYET has a Current Ratio of 0.77. This is a bad value and indicates that RYET is not financially healthy enough and could expect problems in meeting its short term obligations.
  • RYET has a worse Current ratio (0.77) than 68.42% of its industry peers.
  • A Quick Ratio of 0.76 indicates that RYET may have some problems paying its short term obligations.
  • The Quick ratio of RYET (0.76) is worse than 67.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.76
RYET Yearly Current Assets VS Current LiabilitesRYET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

  • RYET shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.20%.
  • The Revenue has been growing slightly by 0.23% in the past year.
EPS 1Y (TTM)-70.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.6%
Revenue 1Y (TTM)0.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-34.49%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RYET Yearly Revenue VS EstimatesRYET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RYET. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RYET Price Earnings VS Forward Price EarningsRYET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RYET Per share dataRYET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for RYET!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

RUANYUN EDAI TECHNOLOGY INC

NASDAQ:RYET (2/2/2026, 8:00:03 PM)

Premarket: 1.09 0 (0%)

1.09

+0.03 (+2.83%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)07-31
Earnings (Next)N/A
Inst Owners0.26%
Inst Owner ChangeN/A
Ins Owners1.69%
Ins Owner ChangeN/A
Market Cap0
Revenue(TTM)13.26M
Net Income(TTM)-2.62M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.77
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.39
BVpS-0.01
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.2%
FCFM N/A
ROA(3y)-19.9%
ROA(5y)N/A
ROE(3y)-301.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.03%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.76
Altman-Z 0.13
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)70.23%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.74%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-34.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-129.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.11%
OCF growth 3YN/A
OCF growth 5YN/A

RUANYUN EDAI TECHNOLOGY INC / RYET FAQ

Can you provide the ChartMill fundamental rating for RUANYUN EDAI TECHNOLOGY INC?

ChartMill assigns a fundamental rating of 0 / 10 to RYET.


Can you provide the valuation status for RUANYUN EDAI TECHNOLOGY INC?

ChartMill assigns a valuation rating of 0 / 10 to RUANYUN EDAI TECHNOLOGY INC (RYET). This can be considered as Overvalued.


How profitable is RUANYUN EDAI TECHNOLOGY INC (RYET) stock?

RUANYUN EDAI TECHNOLOGY INC (RYET) has a profitability rating of 0 / 10.


What is the financial health of RUANYUN EDAI TECHNOLOGY INC (RYET) stock?

The financial health rating of RUANYUN EDAI TECHNOLOGY INC (RYET) is 0 / 10.